U.S. District Judge Patti Saris had seen cases such as this before, and she was fed up.
Another pharmaceutical company was in her court, waiting to be slapped with a multimillion-dollar fine for marketing its drugs for uses that the federal Food & Drug Administration had not approved.
"You can't thumb your nose at the FDA," Saris said.
She sentenced Schering Sales Corp. and its parent company, Schering-Plough Corp., earlier this year to pay $435 million to settle allegations that it lied to the government about drug prices and illegally promoted the drugs Temodar and Intron A for the treatment of cancers for which they were not approved.
More
Another pharmaceutical company was in her court, waiting to be slapped with a multimillion-dollar fine for marketing its drugs for uses that the federal Food & Drug Administration had not approved.
"You can't thumb your nose at the FDA," Saris said.
She sentenced Schering Sales Corp. and its parent company, Schering-Plough Corp., earlier this year to pay $435 million to settle allegations that it lied to the government about drug prices and illegally promoted the drugs Temodar and Intron A for the treatment of cancers for which they were not approved.
More
No comments:
Post a Comment